Elizabeth Ashlynn FalconerSenior AssociateNelson MullinsWebsitewww.nelsonmullins.comOrganization ProfileFull ProfileConnectEmail404-322-6265 Professional Biography Elizabeth focuses her practice in the areas of pharmaceutical and medical device defense, commercial litigation, transportation, and product liability. More Legal and Business Bylines From Elizabeth Ashlynn Falconer FDA Publishes Paper Detailing Actions It Intends to Take Regarding the Uses of AI Across the Medical Product Life Cycle - (Posted On Thursday, March 21, 2024) Current Legal Analysis Court Grants Interlocutory Appeal on AI Fair Use Issue by: James G. Gatto The Lobby Shop: Post Liberation Day Blues [Podcast] by: Caitlin Sickles , Paul Nathanson Countdown To The First Own Risk Assessment by: Kate Bailey The Trump Administration’s Diversity, Equity, and Inclusion (DEI) Executive Orders: A Brief Primer by: Ariel E. Debin Collinsworth , Ryan E. Roberts Unlocking the Secrets of the Endocannabinoid System: A New Frontier in Therapeutic Cannabis Research for Adolescents by: Jennifer Housden What Should Contractors and Grant Recipients do in Response to the DEI Executive Orders? by: Anne Bluth Perry , Katie A. Calogero How Far Do They Reach? Four Issues Entities Should Consider When Analyzing the Trump Administration Executive Orders Related to Diversity, Equity, and Inclusion by: Christopher M. Loveland , Daniel J. Alvarado The DOJ’s Final Rule on Access to U.S. Sensitive Personal Data and Government-Related Data by Countries of Concern or Covered Persons by: Jeffrey D. Neuburger Venezuela’s TPS Designation: Federal Judge Issues Nationwide Order Temporarily Reinstating Program by: Amanda M. Mullane , Andrea M. Sullivan Trump DEI Executive Orders – Impacts on Small Businesses and Small Business Subcontracting by: Anne Bluth Perry , Nikole Snyder We Aren’t in Kansas Anymore – Dr. Oz Confirmed as Head of CMS by: John H. Henson ONE WEEK AWAY: Critical FCC TCPA Dates Coincide on April 11, 2025– Are YOU Ready? by: Eric J. Troutman Michigan Supreme Court Confirms: No Independent Cause of Action for Breach of Implied Covenant of Good Faith by: Ronald A. Spinner , Marc N. Swanson Two Class Actions Target Supplement Promoted for Increasing GLP-1 by: Food and Drug Law at Keller and Heckman Delaware Enacts Significant Changes to Delaware General Corporation Law by: Nicholas O'Keefe , Eric G. Pearson Upcoming Events Apr 30 2025 Workplace Horizons 2025 Apr 7 2025 Understanding the Basics of a Class Action Apr 8 2025 Miller Canfield 2025 HR Spring Training - Kalamazoo Apr 8 2025 Wage & Hour Law Under the Second Trump Administration Print
